TANG KEVIN — SEC insider filings
SEC reporting owner CIK 1178579. 51 insider filings on record with FilingPulse; latest filed 2026-11-20.
Transaction summary — filings shown
Covers the 50 most recent of 51 filings on record, filed 2020-09-01 to 2026-11-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 134 legs across 35 filings — 13,003,356 shares, $119,478,185 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 34 legs across 6 filings — 5,140,694 shares, $24,597,118 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: purchase of 1,052,631 shares @ $14.25 ($14,999,992) in Odonate Therapeutics, Inc., filed 2020-09-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | Chief Executive Officer, Director, 10% owner | 5 | 23 legs · 5,814,606 sh · $62,269,159 | — | 1 |
| Aptevo Therapeutics Inc. (APVO) | — | 3 | 16 legs · 1,436,675 sh · $24,849,231 | 17 legs · 1,760,000 sh · $16,868,647 | — |
| Odonate Therapeutics, Inc. (ODT) | Chief Executive Officer, Director, 10% owner | 4 | 8 legs · 1,439,297 sh · $20,637,608 | 8 legs · 2,747,131 sh · $5,730,557 | — |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | Director, 10% owner | 8 | 12 legs · 922,103 sh · $3,770,254 | 5 legs · 441,290 sh · $1,734,150 | 15 |
| Boundless Bio, Inc. (BOLD) | 10% owner | 14 | 40 legs · 923,779 sh · $2,250,850 | 1 leg · 18,300 sh · $54,351 | — |
| Singular Genomics Systems, Inc. (OMIC) | 10% owner | 2 | 3 legs · 122,416 sh · $1,806,220 | — | 1 |
| Rain Oncology Inc. (RAIN) | 10% owner | 4 | 14 legs · 1,372,418 sh · $1,437,794 | 3 legs · 173,973 sh · $209,413 | 1 |
| Fulcrum Therapeutics, Inc. (FULC) | 10% owner | 2 | 6 legs · 417,562 sh · $1,485,743 | — | — |
| TCR2 THERAPEUTICS INC. (TCRR) | 10% owner | 5 | 10 legs · 468,513 sh · $885,369 | — | 1 |
| Jounce Therapeutics, Inc. (JNCE) | Director, 10% owner | 2 | 2 legs · 85,987 sh · $85,958 | — | 2 |
+1 more issuer among the filings shown — every filing appears in the table below.
Insider filings — TANG KEVIN
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-20 | 4 | Boundless Bio, Inc. (BOLD) jointly with TANG CAPITAL MANAGEMENT LLC | Purchase (P): 22,231 @ $2.40 · Purchase (P): 41,461 @ $2.37 · Purchase (P): 39,920 @ $2.32 | EDGAR |
| 2026-11-17 | 4 | Boundless Bio, Inc. (BOLD) jointly with TANG CAPITAL MANAGEMENT LLC | Purchase (P): 1,395 @ $2.40 · Purchase (P): 12,417 @ $2.40 | EDGAR |
| 2026-11-10 | 4 | Boundless Bio, Inc. (BOLD) jointly with TANG CAPITAL MANAGEMENT LLC | Purchase (P): 1,700 @ $2.40 · Purchase (P): 249 @ $2.40 | EDGAR |
| 2026-11-05 | 4 | Boundless Bio, Inc. (BOLD) jointly with TANG CAPITAL MANAGEMENT LLC | Purchase (P): 2,255 @ $2.40 · Purchase (P): 517 @ $2.40 · Purchase (P): 8,390 @ $2.40 | EDGAR |
| 2026-10-29 | 4 | Boundless Bio, Inc. (BOLD) jointly with TANG CAPITAL MANAGEMENT LLC | Purchase (P): 10,707 @ $2.40 | EDGAR |
| 2026-10-26 | 4 | Boundless Bio, Inc. (BOLD) jointly with TANG CAPITAL MANAGEMENT LLC | Purchase (P): 5,800 @ $2.40 · Purchase (P): 6,234 @ $2.38 · Purchase (P): 9,606 @ $2.38 | EDGAR |
| 2026-10-26 | 3 | Nano Dimension Ltd. (NNDM) jointly with TANG CAPITAL MANAGEMENT LLC | Holdings only — no transactions reported | EDGAR |
| 2026-10-20 | 4 | Boundless Bio, Inc. (BOLD) jointly with TANG CAPITAL MANAGEMENT LLC | Purchase (P): 118,185 @ $2.34 · Purchase (P): 12,790 @ $2.34 · Purchase (P): 18,279 @ $2.33 · Purchase (P): 220 @ $2.37 | EDGAR |
| 2026-08-28 | 4 | Boundless Bio, Inc. (BOLD) jointly with TANG CAPITAL MANAGEMENT LLC | Sale (S): 18,300 @ $2.97 | EDGAR |
| 2026-07-21 | 4 | Boundless Bio, Inc. (BOLD) jointly with TANG CAPITAL MANAGEMENT LLC | Purchase (P): 265 @ $2.44 · Purchase (P): 1,623 @ $2.44 · Purchase (P): 2,975 @ $2.44 | EDGAR |
| 2026-07-20 | 4 | Fulcrum Therapeutics, Inc. (FULC) jointly with TANG CAPITAL MANAGEMENT LLC | Purchase (P): 116,671 @ $3.56 · Purchase (P): 50,945 @ $3.52 | EDGAR |
| 2026-07-16 | 4 | Boundless Bio, Inc. (BOLD) jointly with TANG CAPITAL MANAGEMENT LLC | Purchase (P): 43,878 @ $2.43 · Purchase (P): 1,600 @ $2.44 · Purchase (P): 18,491 @ $2.44 | EDGAR |
| 2026-07-15 | 4 | Fulcrum Therapeutics, Inc. (FULC) jointly with TANG CAPITAL MANAGEMENT LLC | Purchase (P): 12,966 @ $3.54 · Purchase (P): 53,651 @ $3.56 · Purchase (P): 75,952 @ $3.58 · Purchase (P): 107,377 @ $3.56 | EDGAR |
| 2026-07-13 | 4 | Boundless Bio, Inc. (BOLD) jointly with TANG CAPITAL MANAGEMENT LLC | Purchase (P): 7 @ $2.48 · Purchase (P): 43,367 @ $2.43 · Purchase (P): 48,211 @ $2.42 | EDGAR |
| 2026-07-08 | 4 | Boundless Bio, Inc. (BOLD) jointly with TANG CAPITAL MANAGEMENT LLC | Purchase (P): 27,062 @ $2.49 · Purchase (P): 15,810 @ $2.48 · Purchase (P): 14,338 @ $2.46 | EDGAR |
| 2026-07-02 | 4 | Boundless Bio, Inc. (BOLD) jointly with TANG CAPITAL MANAGEMENT LLC | Purchase (P): 25,930 @ $2.54 · Purchase (P): 100 @ $2.50 · Purchase (P): 71,612 @ $2.49 · Purchase (P): 9,821 @ $2.49 | EDGAR |
| 2026-06-29 | 4 | Boundless Bio, Inc. (BOLD) jointly with TANG CAPITAL MANAGEMENT LLC | Purchase (P): 145,880 @ $2.48 · Purchase (P): 510 @ $2.56 · Purchase (P): 75,047 @ $2.55 · Purchase (P): 134 @ $2.54 · Purchase (P): 63,985 @ $2.47 · Purchase (P): 777 @ $2.48 | EDGAR |
| 2026-06-02 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) jointly with TANG CAPITAL MANAGEMENT LLC | Purchase (P): 2,299 @ $15.35 · Purchase (P): 262,682 @ $15.31 · Purchase (P): 343,521 @ $15.28 · Purchase (P): 99 @ $15.34 · Purchase (P): 206,005 @ $15.28 · Other (J): 10,000 (derivative) @ $1.65 | EDGAR |
| 2026-03-03 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Purchase (P): 300,000 @ $13.90 · Purchase (P): 214,839 @ $14.12 · Purchase (P): 1,600 @ $14.38 · Purchase (P): 83,561 @ $14.33 · Purchase (P): 115,792 @ $14.21 · Purchase (P): 184,208 @ $14.22 | EDGAR |
| 2025-08-05 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Purchase (P): 1,000,000 @ $10.12 · Purchase (P): 100,000 @ $11.34 · Purchase (P): 200,000 @ $11.68 | EDGAR |
| 2025-03-04 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Purchase (P): 399,280 @ $7.85 · Purchase (P): 100,720 @ $7.97 · Purchase (P): 351,962 @ $8.02 · Purchase (P): 148,038 @ $8 · Purchase (P): 500,000 @ $7.92 · Purchase (P): 100,000 @ $8.09 | EDGAR |
| 2025-02-27 | 4 | Singular Genomics Systems, Inc. (OMIC) jointly with TANG CAPITAL MANAGEMENT LLC, TANG CAPITAL PARTNERS LP | Disposition to issuer (D): 372,000 | EDGAR |
| 2024-12-09 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Purchase (P): 300,000 @ $8.91 · Purchase (P): 400,000 @ $9.01 · Purchase (P): 500,000 @ $9.09 | EDGAR |
| 2024-09-18 | 4 | Singular Genomics Systems, Inc. (OMIC) jointly with TANG CAPITAL MANAGEMENT LLC, TANG CAPITAL PARTNERS LP | Purchase (P): 50,416 @ $12.74 · Purchase (P): 40,000 @ $15.33 · Purchase (P): 32,000 @ $17.21 | EDGAR |
| 2024-02-14 | 4 | TCR2 THERAPEUTICS INC. (TCRR) jointly with TANG CAPITAL MANAGEMENT LLC, TANG CAPITAL PARTNERS LP | Other (J): 4,394,800 | EDGAR |
| 2024-02-02 | 4 | Rain Oncology Inc. (RAIN) jointly with TANG CAPITAL MANAGEMENT LLC, TANG CAPITAL PARTNERS LP | Code (U): 3,850,513 | EDGAR |
| 2023-12-18 | 4 | Rain Oncology Inc. (RAIN) jointly with TANG CAPITAL MANAGEMENT LLC, TANG CAPITAL PARTNERS LP | Sale (S): 24,406 @ $1.21 · Sale (S): 109,435 @ $1.20 · Sale (S): 40,132 @ $1.21 | EDGAR |
| 2023-10-13 | 4 | Rain Oncology Inc. (RAIN) jointly with TANG CAPITAL MANAGEMENT LLC, TANG CAPITAL PARTNERS LP | Purchase (P): 74,812 @ $0.97 · Purchase (P): 25,188 @ $0.98 · Purchase (P): 52,514 @ $0.98 · Purchase (P): 47,486 @ $0.99 · Purchase (P): 84,145 @ $0.99 | EDGAR |
| 2023-06-01 | 4 | Rain Oncology Inc. (RAIN) jointly with TANG CAPITAL MANAGEMENT LLC, TANG CAPITAL PARTNERS LP | Purchase (P): 347,932 @ $1.05 · Purchase (P): 200,000 @ $1 · Purchase (P): 32,890 @ $1.06 · Purchase (P): 2,016 @ $1.08 · Purchase (P): 5,930 @ $1.06 · Purchase (P): 161,180 @ $1.08 · +3 more | EDGAR |
| 2023-05-30 | 4 | TCR2 THERAPEUTICS INC. (TCRR) jointly with TANG CAPITAL MANAGEMENT LLC, TANG CAPITAL PARTNERS LP | Purchase (P): 50,000 @ $1.72 | EDGAR |
| 2023-05-15 | 4 | TCR2 THERAPEUTICS INC. (TCRR) jointly with TANG CAPITAL MANAGEMENT LLC, TANG CAPITAL PARTNERS LP | Purchase (P): 38,765 @ $1.95 · Purchase (P): 6,183 @ $1.95 | EDGAR |
| 2023-05-10 | 4 | TCR2 THERAPEUTICS INC. (TCRR) jointly with TANG CAPITAL MANAGEMENT LLC, TANG CAPITAL PARTNERS LP | Purchase (P): 57,073 @ $1.95 · Purchase (P): 20,141 @ $1.95 · Purchase (P): 6,774 @ $1.95 | EDGAR |
| 2023-05-05 | 4 | Jounce Therapeutics, Inc. (JNCE) jointly with TANG CAPITAL MANAGEMENT LLC, TANG CAPITAL PARTNERS LP | Code (U): 5,300,087 @ $1.85 · Other (J): 10,000 @ $9,737.70 | EDGAR |
| 2023-05-05 | 4 | TCR2 THERAPEUTICS INC. (TCRR) jointly with TANG CAPITAL MANAGEMENT LLC, TANG CAPITAL PARTNERS LP | Purchase (P): 18,513 @ $1.85 · Purchase (P): 104,241 @ $1.86 · Purchase (P): 95,759 @ $1.90 · Purchase (P): 71,064 @ $1.94 | EDGAR |
| 2023-03-14 | 4 | Jounce Therapeutics, Inc. (JNCE) jointly with TANG CAPITAL MANAGEMENT LLC, TANG CAPITAL PARTNERS LP | Purchase (P): 65,701 @ $0.99 · Purchase (P): 20,286 @ $1.02 | EDGAR |
| 2022-08-24 | 4 | LA JOLLA PHARMACEUTICAL CO (LJPC) | Code (U): 9,607,934 @ $6.23 · Disposition to issuer (D): 18,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · +5 more | EDGAR |
| 2022-08-24 | 4 | LA JOLLA PHARMACEUTICAL CO (LJPC) jointly with TANG CAPITAL PARTNERS LP, TANG CAPITAL MANAGEMENT LLC, Hearne Michael S | Code (U): 9,607,934 @ $6.23 · Code (U): 3,519.32 (derivative) | EDGAR |
| 2022-01-14 | 4 | LA JOLLA PHARMACEUTICAL CO (LJPC) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2021-12-01 | 4 | LA JOLLA PHARMACEUTICAL CO (LJPC) jointly with TANG CAPITAL PARTNERS LP, TANG CAPITAL MANAGEMENT LLC, Hearne Michael S | Sale (S): 193,403 @ $4.10 · Sale (S): 6,597 @ $3.95 · Sale (S): 63,745 @ $3.95 · Sale (S): 136,255 @ $3.76 · Sale (S): 41,290 @ $3.66 | EDGAR |
| 2021-11-26 | 4 | Aptevo Therapeutics Inc. (APVO) jointly with TANG CAPITAL MANAGEMENT LLC, TANG CAPITAL PARTNERS LP | Sale (S): 161,336 @ $13.52 · Sale (S): 124,509 @ $12.45 · Sale (S): 75,491 @ $11.74 · Sale (S): 149,111 @ $11.19 · Sale (S): 50,889 @ $10.43 · Sale (S): 200,000 @ $10.07 · +1 more | EDGAR |
| 2021-11-22 | 4 | Aptevo Therapeutics Inc. (APVO) jointly with TANG CAPITAL MANAGEMENT LLC, TANG CAPITAL PARTNERS LP | Sale (S): 43,213 @ $9.38 · Sale (S): 152,764 @ $8.32 · Sale (S): 4,023 @ $8.00 · Sale (S): 169,533 @ $8.09 · Sale (S): 30,467 @ $8.01 · Sale (S): 183,333 @ $7.52 · +4 more | EDGAR |
| 2021-11-19 | 4 | Odonate Therapeutics, Inc. (ODT) jointly with TANG CAPITAL PARTNERS LP, TANG CAPITAL MANAGEMENT LLC, Hearne Michael S | Sale (S): 468,849 @ $2.66 · Sale (S): 31,151 @ $1.99 · Sale (S): 500,000 @ $2.02 · Sale (S): 287,577 @ $2.20 · Sale (S): 212,423 @ $1.97 · Sale (S): 500,000 @ $1.88 · +2 more | EDGAR |
| 2021-06-01 | 4 | LA JOLLA PHARMACEUTICAL CO (LJPC) jointly with TANG CAPITAL PARTNERS LP, TANG CAPITAL MANAGEMENT LLC, Hearne Michael S | Purchase (P): 1,286 @ $4.50 · Purchase (P): 184,642 @ $4.47 · Purchase (P): 15,358 @ $4.29 · Purchase (P): 43,734 @ $4.53 | EDGAR |
| 2021-05-26 | 4 | LA JOLLA PHARMACEUTICAL CO (LJPC) jointly with TANG CAPITAL PARTNERS LP, TANG CAPITAL MANAGEMENT LLC, Hearne Michael S | Purchase (P): 104,403 @ $3.68 · Purchase (P): 95,597 @ $3.77 · Purchase (P): 31,782 @ $3.83 · Purchase (P): 166,932 @ $4.26 | EDGAR |
| 2021-05-04 | 4 | LA JOLLA PHARMACEUTICAL CO (LJPC) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2020-12-23 | 4 | Odonate Therapeutics, Inc. (ODT) jointly with TANG CAPITAL PARTNERS LP, TANG CAPITAL MANAGEMENT LLC, Hearne Michael S | Purchase (P): 62,144 @ $14.58 · Purchase (P): 37,856 @ $14.58 · Purchase (P): 36,646 @ $15.17 · Purchase (P): 63,354 @ $15.43 · Purchase (P): 75,784 @ $15.71 | EDGAR |
| 2020-11-06 | 4 | Aptevo Therapeutics Inc. (APVO) jointly with TANG CAPITAL MANAGEMENT LLC, TANG CAPITAL PARTNERS LP | Purchase (P): 68,296 @ $10.63 · Purchase (P): 88,379 @ $13.11 · Purchase (P): 160,000 @ $13.83 · Purchase (P): 99,854 @ $13.65 · Purchase (P): 60,146 @ $16.33 · Purchase (P): 160,000 @ $16.84 · +10 more | EDGAR |
| 2020-09-30 | 4 | Odonate Therapeutics, Inc. (ODT) jointly with TANG CAPITAL PARTNERS LP, TANG CAPITAL MANAGEMENT LLC, Lemkey John G, Hearne Michael S | Purchase (P): 100,000 @ $13.06 · Purchase (P): 10,882 @ $13.85 | EDGAR |
| 2020-09-09 | 4 | LA JOLLA PHARMACEUTICAL CO (LJPC) jointly with TANG CAPITAL PARTNERS LP, TANG CAPITAL MANAGEMENT LLC, Hearne Michael S | Purchase (P): 67,552 @ $3.82 · Purchase (P): 84,152 @ $3.90 · Purchase (P): 48,296 @ $4.01 · Purchase (P): 78,369 @ $4.03 | EDGAR |
| 2020-09-01 | 4 | Odonate Therapeutics, Inc. (ODT) jointly with TANG CAPITAL PARTNERS LP, TANG CAPITAL MANAGEMENT LLC, Lemkey John G, Hearne Michael S | Purchase (P): 1,052,631 @ $14.25 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1178579 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs